13D Filing: Aisling Capital III LP and Transenterix Inc. (TRXC)

Page 1 of 12

Transenterix Inc. (NYSEMKT:TRXC): Dennis Purcell’s Aisling Capital III LP filed an amended 13D.

You can check out Aisling Capital III LP’s latest holdings and filings here.

Please follow Aisling Capital III LP (if you aren’t already doing so) to get real-time email alerts whenever we publish an article about Aisling Capital III LP or update its stock holdings.

Follow Dennis Purcell's Aisling Capital

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Aisling Capital III 11,490,831 0 11,490,831 0 11,490,831 5.8%
Aisling Capital Partners III 11,490,831 0 11,490,831 0 11,490,831 5.8%
Aisling Capital Partners III 11,490,831 0 11,490,831 0 11,490,831 5.8%
Steve Elms 0 11,490,831 0 11,490,831 11,490,831 5.8%
Dennis Purcell 0 11,490,831 0 11,490,831 11,490,831 5.8%
Andrew Schiff 0 11,490,831 0 11,490,831 11,490,831 5.8%

Page 1 of 12 – SEC Filing



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D/A
Under the Securities Exchange Act of 1934
(Amendment No. 5)*


TransEnterix, Inc.
(Name of Issuer)
Common Stock, $0.001 par value per share
(Title of Class of Securities)
89366M102
(CUSIP Number)
Aisling Capital
888 Seventh Avenue, 12th Floor
New York, NY 10106
(212) 651-6380
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
November 16, 2017
(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.  ¨
Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.
*
The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Follow Asensus Surgical Inc. (NYSEMKT:ASXC)

Page 1 of 12